[LABP] QoQ Quarter Result on 30-Jun-2022 [#Q2]

Stock
[LABP] Landos Biopharma, Inc.
Announcement Date
11-Aug-2022
Financial Year
2022
Quarter
30-Jun-2022 [#Q2]
Profit Trend
QoQ- 23.51%
YoY- -375.86%
Quarter Report
LABP's Result
LABP's Financial Summary
View:
Show?
Quarter Result
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
Revenue 0 0 0 0 0 -18,000 0 -
PBT -6,034 -5,232 -7,896 -11,284 -14,864 -20,097 -12,604 -38.83%
Tax -445 -1,352 67 18 -89 320 191 -
NP -5,589 -3,880 -7,963 -11,302 -14,775 -20,097 -12,604 -41.87%
Tax Rate - - - - - - - -
Total Cost 5,589 3,880 7,963 11,302 14,775 2,097 12,604 -41.87%
Ratio Analysis
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 111.65 0.00 -
Per Share
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
EPS -0.86 -0.96 -1.98 -2.81 -3.67 -5.20 -3.20 -58.38%
EPS Diluted -0.86 -0.96 -1.98 -2.81 -3.67 -5.20 -3.20 -58.38%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.